author-photo

Antonio Molinés

Ciber

15

Papers

505

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

2021 Frontiers in Pediatrics
Show All
- Source
- Cite
- Save
Citations (2)
Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.

2012 Leukemia
Show All
- Source
- Cite
- Save
Citations (45)
Oesophageal squamous cell carcinoma in a young adult with IL-12Rβ1 deficiency

2010 Journal of Medical Genetics
Show All
- Source
- Cite
- Save
Citations (25)
One Year Reinductions with Vincristine, Asparaginase and Prednisone as Post-Remission Therapy Improves Outcome in Children with Intermediate Risk (IR) Acute Lymphoblastic Leukemia (ALL).

2009 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network

2007 Journal of Medical Genetics
Show All
- Source
- Cite
- Save
Citations (47)
Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation

2006 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (33)
Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (46)
Comparison of Intensive Chemotherapy (CHT), Allogeneic (ALLO) or Autologous (AUTO) Stem Cell Transplantation (SCT) as Post-Remission Treatment for Children with Very High-Risk Acute Lymphoblastic Leukemia (VHR-ALL). Final Results of the PETHEMA ALL-93 Trial.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial

2002 Haematologica
Show All
- Source
- Cite
- Save
Citations (44)